Welcome to the 2nd mRNA Analytical Development Summit!
In the face of the pandemic, renewed mRNA vaccine technologies presented a huge therapeutic potential for global treatment.
Now, as the development of mRNA-based vaccines and therapeutics continues to surge through biopharma and academia, it is more critical than ever that we leverage the value of optimized analytics and ensure the rapid development, approval, and commercialization of safe and efficacious mRNA therapeutics & vaccines.
Through in-depth case studies showcasing the latest analytical advancements, this technical forum will delve deep into:
Optimizing In-Vitro & In Vivo Potency Assays for Robust Translation into Clinical Setting
Innovating Analytical Methods to Successfully Purify & Characterize mRNA in Drug Substance & mRNA-Lipid Nanoparticles
Improving Immunogenicity Challenges of Genetic Vaccines While Maintaining Safety & Efficacy
Accelerating Regulatory Approvals by Avoiding Common Mistakes Observed in Regulatory Submissions for Analytical Method Validation
Uniting 80+ Senior Scientists, Directors, and Heads of Analytical Development, Quality Control, CMC & Regulatory, this unrivaled forum will be your one-stop-shop for improving your research, development, and production processes to develop higher-quality mRNA therapeutics and vaccines, giving you a better understanding of the analytical methods of the future and allowing you to safeguard your regulatory submissions in 2023 and beyond.
What You Can Expect
18+ World-Class Speakers
11+ Case Studies
6+ Hours of Dedicated Networking
1 Roundtable Discussions
2 Engaging Panel Discussions